Challenges in Treating Intraocular Inflammation in HIV Patients

References

• Moshfeghi D, Dodds E, Couto C, et al. Diagnostic approaches to severe, atypical toxoplasmosis mimicking acute retinal necrosis. Ophthalmology. Apr, 2004;111:716–725. PubMed PMID: 15051204. doi:10.1016/j.ophtha.2003.07.004.
   PubMed Web of Science ®Google Scholar
• Cochereau-Massin I, LeHoang P, Lautier-Frau M, et al. Ocular toxoplasmosis in human immunodeficiency virus-infected patients. Am J Ophthalmol. Aug, 1992;15(114):130–135. doi:10.1016/S0002-9394(14)73975-3.
   Google Scholar
• Rodgers C, Harris J. Ocular toxoplasmosis in HIV infection. Int J STD AIDS. Aug-Sep, 1996;7:307–309. doi:10.1258/0956462961918068.
   PubMed Web of Science ®Google Scholar
• Moorthy R, Smith R, Rao N. Progressive ocular toxoplasmosis in patients with acquired immunodeficiency syndrome. Am J Ophthalmol. Jun, 1993;15(115):742–747. doi:10.1016/S0002-9394(14)73641-4.
   Google Scholar
• Forster D, Dugel P, Frangieh G, Liggett P, Rao N. Rapidly progressive outer retinal necrosis in the acquired immunodeficiency syndrome. Am J Ophthalmol. Oct 15, 1990;ll0:341–348. doi:10.1016/S0002-9394(14)77012-6.
   Google Scholar
• Engstrom R Jr, Holland G, Margolis T, et al. The progressive outer retinal necrosis syndrome: a variant of necrotizing herpetic retinopathy in patients with AIDS. Ophthalmology. Sep, 1994;101:1488–1502. doi:10.1016/S0161-6420(94)31142-0.
   PubMed Web of Science ®Google Scholar
• Margolis T, Lowder C, Holland G, et al. Varicella zoster virus retinitis in patients with the acquired immunodeficiency syndrome. Am J Ophthalmol. Aug, 1991;15(112):119–131. doi:10.1016/S0002-9394(14)76690-5.
   Google Scholar
• Greven C, Ford J, Stanton C, et al. Progressive outer retinal necrosis secondary to Varicella zoster virus in acquired immune deficiency syndrome. Retina. 1995;15:14–20. doi:10.1097/00006982-199515010-00003.
   PubMed Web of Science ®Google Scholar
• Holland G. The progressive outer retinal necrosis syndrome. Int Ophthalmol. 1994;18:163–165. doi:10.1007/BF00915966.
   PubMed Web of Science ®Google Scholar
• Johnston W, Holland G, Engstrom R Jr., Rimmer S. Recurrence of presumed Varicella zoster virus retinopathy in patients with acquired immunodeficiency syndrome. Am J Ophthalmol. 1993;116:42–50. doi:10.1016/S0002-9394(14)71742-8.
   PubMed Web of Science ®Google Scholar
• Agarwal S, Cunningham-Rundles C. Thymoma and immunodeficiency (Good syndrome): a report of 2 unusual cases and review of the literature. Ann Allergy Asthma Immunol. 2007;98:185–190. doi:10.1016/S1081-1206(10)60695-3.
   PubMed Web of Science ®Google Scholar
• Christopoulos P, Fisch P. acquired t-cell immunodeficiency in thymoma patients. Crit Rev Immunol. 2016;36(4):315–327. doi:10.1615/CritRevImmunol.v36.i4.
   PubMed Web of Science ®Google Scholar
• Lee A, Chockalingam G. Good syndrome: immunodeficiency associated with thymoma. Intern Med J. 2018;48(7):891–892. doi:10.1111/imj.2018.48.issue-7.
   PubMed Web of Science ®Google Scholar
• Geerlings S, Hoepelman A. Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol. 1999;26:259–265. doi:10.1111/fim.1999.26.issue-3-4.
   PubMed Web of Science ®Google Scholar
• Barr T, Helms C, Grant K, Messaoudi I. Opposing effects of alcohol on the immune system. Prog Neuropsychopharmacol Biol Psychiatry. 2016;65:242–251. doi:10.1016/j.pnpbp.2015.09.001.
   PubMed Web of Science ®Google Scholar
• Elkins B, Holland G, Opremcak E, et al. Ocular toxoplasmosis misdiagnosed as cytomegalovirus retinopathy in immunocompromised patients. Ophthalmology. 1994;101:499–507. doi:10.1016/S0161-6420(13)31267-6.
   PubMed Web of Science ®Google Scholar
• Ridley M, McDonald H, Sternberg P Jr, Blumenkranz M, Zarbin M, Schachat A. Retinal manifestations of ocular lymphoma (reticulum cell sarcoma). Ophthalmology. 1992;99:1153–1160. doi:10.1016/S0161-6420(92)31834-2.
   PubMed Web of Science ®Google Scholar
• Gore D, Gore S, Visser L. Progressive outer retinal necrosis: outcomes in the intravitreal era. Arch Ophthalmol. 2012;130:700–706. doi:10.1001/archophthalmol.2011.2622.
   PubMedGoogle Scholar
• Moorthy R, Weinberg D, Teich S, et al. Management of varicella zoster virus retinitis in AIDS. Br J Ophthalmol. 1997;81:189–194. doi:10.1136/bjo.81.3.189.
   PubMed Web of Science ®Google Scholar
• Workowoski K, Bolan G. Sexually transmitted diseases treatment guidelines. MMWR Morb Mortal Wkly Rep. 2015;64:1–137.
   PubMed Web of Science ®Google Scholar
• Rolfs R, Joesoef M, Hendershot E, et al. The syphilis and HIV study group. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. N Engl J Med. 1997;337:307–314. doi:10.1056/NEJM199707313370504.
   PubMed Web of Science ®Google Scholar
• Ghanem K, Erbelding E, Wiener Z, Rompalo A. Serological response to syphilis treatment in HIV-positive and HIV-negative patients attending sexually transmitted diseases clinics. Sex Transm Infect. 2007;83:97–101. doi:10.1136/sti.2006.021402.
   PubMed Web of Science ®Google Scholar
• Sena A, Wolff M, Martin D, et al. Predictors of serological cure and serofast state after treatment in HIV-negative persons with early syphilis. Clin Infect Dis. 2011;53:1092–1099. doi:10.1093/cid/cir671.
   PubMed Web of Science ®Google Scholar
• Johnson PD, Graves SR, Stewart L, Warren R, Dwyer B, Lucas CR. Specific syphilis serological tests may become negative in HIV infection. AIDS. 1991;5(4):419–423. doi:10.1097/00002030-199104000-00010.
   PubMed Web of Science ®Google Scholar
• Marra C, Maxwell C, Tantalo L, et al. Normalization of cerebrospinal fluid abnormalities after neurosyphilis therapy: does HIV status matter? Clin Infect Dis. 2004;38:1001–1006. doi:10.1086/cid.2004.38.issue-7.
   PubMed Web of Science ®Google Scholar
• Marra C, Maxwell C, Tantalo L, Sahi S, Lukehart S. Normalization of serum rapid plasma reagin titer predicts normalization of cerebrospinal fluid and clinical abnormalities after treatment of neurosyphilis. Clin Infect Dis. 2008;47:893–899. doi:10.1086/592959.
   PubMed Web of Science ®Google Scholar
• Hegde H, Robbins S. Anergy and human immunodeficiency virus infection. Med Hypotheses. 2001;56:376–380. doi:10.1054/mehy.2000.1220.
   PubMed Web of Science ®Google Scholar
• Janis E, Allen D, Glesby M, et al. Tuberculin skin test reactivity, anergy, and HIV infection in hospitalized patients. Longcope firm of the osler medical housestaff. Am J Med. 1996;100:186–192. doi:10.1016/S0002-9343(97)89457-0.
   PubMed Web of Science ®Google Scholar
• Harper T, Miller D, Schiffman J, Davis J. Polymerase chain reaction analysis of aqueous and vitreous specimens in the diagnosis of posterior segment infectious uveitis. Am J Ophthalmol. 2009;147:140–147.e2. doi:10.1016/j.ajo.2008.07.043.
   PubMed Web of Science ®Google Scholar
• Chronopoulos A, Roquelaure D, Souteyrand G, Seebach J, Schutz J, Thumann G. Aqueous humor polymerase chain reaction in uveitis - utility and safety. BMC Ophthalmol. 2016;16:189. doi:10.1186/s12886-016-0369-z.
   PubMed Web of Science ®Google Scholar
• Kempen J, Min Y, Freeman W, et al. Risk of immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis. Ophthalmology. 2006;113:684–694. doi:10.1016/j.ophtha.2005.10.067.
   PubMed Web of Science ®Google Scholar
• Studies of ocular complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group. Foscarnet-ganciclovir cytomegalovirus retinitis trial: 5. Clinical features of cytomegalovirus retinitis at diagnosis. Am J Ophthalmology. 1997;124:141–157. doi:10.1016/S0002-9394(14)70778-0.
   PubMed Web of Science ®Google Scholar
• Jabs D, Van Natta M, Holbrook J, Kempen J, Meinert C, Davis M. The studies of ocular complications of AIDS research group. Longitudinal study of the ocular complications of AIDS: 2. Ocular examination results at enrollment. Ophthalmology. 2007;114(4):787–793. doi:10.1016/j.ophtha.2006.07.065.
   PubMed Web of Science ®Google Scholar
• Nguyen Q, Kempen J, Bolton S, Dunn J, Jabs D. Immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis after highly active antiretroviral therapy. Am J Ophthalmol. 2000;129(5):634–639. doi:10.1016/S0002-9394(00)00356-1.
   PubMed Web of Science ®Google Scholar
• Robinson M, Reed G, Csaky K, Polis M, Whitcup S. Immune-recovery uveitis in patients with cytomegalovirus retinitis taking highly active antiretroviral therapy. Am J Ophthalmol. 2000;130(1):49–56. doi:10.1016/S0002-9394(00)00530-4.
   PubMed Web of Science ®Google Scholar
• Karavellas M, Plummer D, Macdonald J, et al. Incidence of immune recovery vitritis in cytomegalovirus retinitis patients following institution of successful highly active antiretroviral therapy. J Infect Dis. 1999;179(3):697–700. doi:10.1086/jid.1999.179.issue-3.
   PubMed Web of Science ®Google Scholar
• Ortega-Larrocea G, Espinosa E, Reyes-Teran G. Lower incidence and severity of cytomegalovirus- associated immune recovery uveitis in HIV-infected patients with delayed highly active antiretroviral therapy. AIDS. 2005;19(7):735–738. doi:10.1097/01.aids.0000166100.36638.97.
   PubMed Web of Science ®Google Scholar
• Jabs D. Cytomegalovirus retinitis and the acquired immunodeficiency syndrome–bench to bedside: LXVII Edward Jackson memorial lecture. Am J Ophthalmol. 2011;151(2):198–216.e1. doi:10.1016/j.ajo.2010.10.018.
   PubMed Web of Science ®Google Scholar
• Bansal R, Gupta A, Gupta V, Dogra MR, Sharma A, Bambery P. Tubercular serpiginous-like choroiditis presenting as multifocal serpiginoid choroiditis. Ophthalmology. 2012;119(11):2334–2342. doi:10.1016/j.ophtha.2012.05.034.
   PubMed Web of Science ®Google Scholar
• Agarwal A, Handa S, Aggarwal K, et al. The role of dexamethasone implant in the management of tubercular uveitis. Ocul Immunol Inflamm. 2018;26(6):884–892. doi:10.1080/09273948.2017.1400074.
   PubMed Web of Science ®Google Scholar
• Jain L, Panda K, Basu S. Clinical outcomes of adjunctive sustained-release intravitreal dexamethasone implants in tuberculosis-associated multifocal serpigenoid choroiditis. Ocul Immunol Inflamm. 2018;26(6):877–883. doi:10.1080/09273948.2017.1383446.
   PubMed Web of Science ®Google Scholar
• Hasanreisoglu M, Gulpinar Ikiz G, Aktas Z, Ozdek S. Intravitreal dexamethasone implant as an option for anti-inflammatory therapy of tuberculosis uveitis. Int Ophthalmol. 2019;39(2):485–490. doi:10.1007/s10792-018-0831-4.
   PubMed Web of Science ®Google Scholar
• Holland G, Engstrom R, Glasgow B, et al. Ocular toxoplasmosis in patients with the acquired immunodeficiency syndrome. Am J Ophthalmol. 1988;106:653–667. doi:10.1016/0002-9394(88)90697-6.
   PubMed Web of Science ®Google Scholar
• Holland G. Ocular toxoplasmosis in the immunocompromised host. Int Ophthalmol. 1989;13:399–402. doi:10.1007/BF02306488.
   PubMed Web of Science ®Google Scholar
• Crosson J, Laird P, Grossniklaus H, Hendrick A. Toxoplasma chorioretinitis diagnosed by histopathology in a patient with AIDS. Retin Cases Brief Rep. 2015;9(2):162–163. doi:10.1097/ICB.0000000000000126.
   PubMedGoogle Scholar
• Centers for disease control and prevention. Parasites – toxoplasmosis (Toxoplasma infection). https://www.cdc.gov/parasites/toxoplasmosis/health_professionals/index.html#tx Accessed September 25, 2019.
   Google Scholar
• Silveira C, Belfort R Jr, Muccioli C, et al. The effect of long-term intermittent trimethoprim/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis. Am J Ophthalmol. 2002;134:41–46. doi:10.1016/S0002-9394(02)01527-1.
   PubMed Web of Science ®Google Scholar
• Gagliuso D, Teich S, Friedman A, Orellana J. Ocular toxoplasmosis in AIDS patients. Trans Am Ophthalmol Soc. 1990;88:63–86.
   PubMedGoogle Scholar
• Felix J, Lira R, Zacchia R, Toribio J, Nascimento M, Arieta C. Trimethoprim-sulfamethoxazole versus placebo to reduce the risk of recurrences of Toxoplasma gondii retinochoroiditis: randomized controlled clinical trial. Am J Ophthalmol. 2014;157(762–766):e1. doi:10.1016/j.ajo.2013.12.022.
   PubMedGoogle Scholar
• Pepose J, Holland G, Nestor M, Cochran A, Foos R. Acquired immune deficiency syndrome. Pathogenic mechanisms of ocular disease. Ophthalmology. 1985;92(4):472–484. doi:10.1016/S0161-6420(85)34008-3.
   PubMed Web of Science ®Google Scholar
• Kuppermann B, Petty J, Richman D, et al. Correlation between CD4+ counts and prevalence of cytomegalovirus retinitis and human immunodeficiency virus-related noninfectious retinal vasculopathy in patients with acquired immunodeficiency syndrome. Am J Ophthalmol. 1993;115(5):575–582. doi:10.1016/S0002-9394(14)71453-9.
   PubMed Web of Science ®Google Scholar
• Kaplan J, Benson C, Holmes K, et al. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV medicine association of the infectious diseases society of America. MMWR Recomm Rep. 2009;58(RR–4):1–207.
   Google Scholar